Kiener Peter A 4
4 · Cue Biopharma, Inc. · Filed Jan 4, 2024
Insider Transaction Report
Form 4
Kiener Peter A
Director
Transactions
- Award
Stock Option (right to buy)
2024-01-02+24,400→ 24,400 totalExercise: $2.78Exp: 2034-01-01→ Common Stock (24,400 underlying)
Footnotes (2)
- [F1]Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy.
- [F2]This option was granted on January 2, 2024. The shares underlying the option are scheduled to vest in full on the anniversary date of the grant date.